SLC26A5 and auditory system disorder: Our finding that AAV-ie-K558R partially restored hearing function in Prestin KO mice represents a substantial advance in the field of gene therapies targeting auditory diseases, since the effective delivery of genes into OHCs has always been a significant challenge.16,40 In this study, we achieved only partial restoration of the auditory function with AAV-ie-K558R.